Ailux Biologics Enters into License Agreement with Janssen Biotech

Ailux Biologics Enters into License Agreement with Janssen Biotech

10/12/24, 9:06 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Industry
therapeutics
pharmaceutical
artificial intelligence
biotechnology
Type
agreement
Ailux Biologics, a division of XtalPi, has entered into a license agreement with Janssen Biotech, a Johnson & Johnson company. The agreement grants Janssen and its affiliates a non-exclusive license to leverage Ailux Biologics' XtalFold™ platform for the discovery and engineering of biologics.

Company Info

Company
Ailux Biologics a Division of XtalPi
Location
cambridge, massachusetts, united states
Additional Info
Ailux Biologics is a division of XtalPi Inc., a global leader in AI drug discovery.